Lataa...
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma
Lung cancer is the leading cause of cancer death worldwide with low response rates to conventional chemotherapy. New promising therapies have emerged based on programmed cell death protein 1 (PD-1) immunity checkpoint inhibitors (ICI), including anti-PD-1, such as nivolumab and pembrolizumab, or pro...
Tallennettuna:
| Julkaisussa: | J Thorac Dis |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353738/ https://ncbi.nlm.nih.gov/pubmed/30775032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.103 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|